Showing results (11-20 of 769) with videos related to
Sort By:
Pageof 77
Antimicrobial Agents and Chemotherapy|November 1, 1995
DNA sequence differences of ampD mutants of Citrobacter freundiiP Stapleton, K Shannon, I PhillipsThe American Journal of Medicine|June 30, 1986
Prevalence and mechanisms of aminoglycoside resistance. A ten-year studyI Phillips, A King, K ShannonThe Journal of Antimicrobial Chemotherapy|December 1, 1995
Resistance to imipenem in Pseudomonas aeruginosaA King, K Shannon, I PhillipsThe Journal of Antimicrobial Chemotherapy|June 1, 1985
Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamasesK Shannon, A King, I PhillipsThe Journal of Antimicrobial Chemotherapy|November 1, 1989
Mechanisms of gentamicin resistance in gram-negative bacilli in Riyadh, Kingdom of Saudi ArabiaA Moaz, K Shannon, I PhillipsThe Journal of Antimicrobial Chemotherapy|April 1, 1984
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acidA King, K Shannon, I PhillipsAntimicrobial Agents and Chemotherapy|March 1, 1994
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibioticsP J Wu, K Shannon, I PhillipsThe Journal of Antimicrobial Chemotherapy|December 1, 1995
Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coliP J Wu, K Shannon, I PhillipsFEMS Microbiology Letters|February 1, 1990
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15K Shannon, H Williams, A King, et al.Antimicrobial Agents and Chemotherapy|April 1, 1982
In vitro antibacterial activity of norfloxacin (MK-0366)A King, C Warren, K Shannon, et al.Pageof 77